Rchr
J-GLOBAL ID：202001008779276012
Update date: Feb. 01, 2024
Ferdous Tarannum
フェルドゥス タランヌム | Ferdous Tarannum
Affiliation and department：
Job title：
Academic Researcher
Research field (7)：
Human pathology
, Hematology and oncology
, Tumor diagnostics and therapeutics
, Immunology
, Cell biology
, Molecular biology
, Tumor biology
Research keywords (6)：
Biotechnology/Genetic Engineering
, Pathology
, Immunology
, Cell biology
, Molecular Biology
, Oncology
Research theme for competitive and other funds (4)：
- 2016 - 2019 Development of the combined therapy with an immune check point inhibitor against anticancer agent-resistant oral squamous cell carcinoma cells
- 2015 - 2017 Development of new predictive factors for malignant alteration of oral cancer by the functional analysis of the factors in regard to loss of anchorage dependence.
- 2014 - 2017 Development of the new therapeutic strategy for recurrence/metastatic oral cancer -toward natural life with oral cancer-
- 2013 - 2016 Identification of new predictive factor for combined chemotherapy with docetaxel against oral cancer
Papers (33)：
-
Takanori Takenawa, Koji Harada, Tarannum Ferdous, Keisuke Kawasaki, Yasuhiro Kuramitsu, Katsuaki Mishima. Silencing of Tropomyosin 1 suppresses the proliferation, invasion and metastasis of oral squamous cell carcinoma in vitro. Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology. 2023. 35. 3. 282-287
-
Koji Harada, Tarannum Ferdous, Rieko Fujiwara, Kenji Watanabe, Yoichi Mizukami, Katsuaki Mishima. An elemental diet protects mouse salivary glands from 5-fluorouracil-induced atrophy. Oncology Letters. 2022. 23. 6
-
Rieko Fujiwara, Koji Harada, Tarannum Ferdous, Katsuaki Mishima. Amino Acids May Have Protective Effects on Salivary Glands of 5-FU-administered Mice. IN VIVO. 2022. 36. 1. 198-205
-
Koji Harada, Tarannum Ferdous, Katsuaki Mishima. Efficacy of a Novel Oral Chemotherapeutic Agent, TAS-102, Against Human Oral Squamous Cell Carcinoma Cells. ANTICANCER RESEARCH. 2021. 41. 12. 6039-6049
-
Koji Harada, Tarannum Ferdous, Katsuaki Mishima. Efficacy of a Novel Oral Chemotherapeutic Agent, TAS-102, Against Human Oral Squamous Cell Carcinoma Cells. Anticancer research. 2021. 41. 12. 6039-6049
ｍore...
MISC (1)：
-
Tetsuya Tamatani, Natsumi Takamaru, Tarannum Ferdous, Daisuke Uchida, Kenji Fujisawa, Hirokazu Nagai, Youji Miyamoto. The expression of survivin in human oral squamous cell carcinoma and its relationship with clinical factors. CANCER RESEARCH. 2011. 71
Return to Previous Page
